Thalys Medical Technology Group Corporation (SHA:603716)
China · Delayed Price · Currency is CNY 15.95
-0.64 (-3.86%)
Nov 2, 2026, 3:00 PM CST
SHA:603716 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 76.59 | 130.94 | 209.44 | 278.59 | 394.54 | 473.55 |
Trading Asset Securities | 2.22 | 1.35 | - | - | - | 12 |
Cash & Short-Term Investments | 78.81 | 132.29 | 209.44 | 278.59 | 394.54 | 485.55 |
Cash Growth | -44.07% | -36.84% | -24.82% | -29.39% | -18.74% | -26.63% |
Accounts Receivable | 579.97 | 765.02 | 1,361 | 1,608 | 1,832 | 1,830 |
Other Receivables | 48.94 | 58.66 | 119.63 | 88.81 | 189.1 | 346.41 |
Receivables | 628.91 | 823.68 | 1,481 | 1,697 | 2,021 | 2,177 |
Inventory | 180.21 | 223.38 | 326.16 | 341.6 | 420.75 | 463.61 |
Prepaid Expenses | - | - | - | - | 1 | - |
Other Current Assets | 73.75 | 59.02 | 70.62 | 77.88 | 112.79 | 116.04 |
Total Current Assets | 961.68 | 1,238 | 2,087 | 2,395 | 2,951 | 3,242 |
Property, Plant & Equipment | 106.38 | 127.87 | 159.38 | 204.24 | 233.94 | 277.43 |
Long-Term Investments | 271.76 | 253.25 | 284.96 | 277.44 | 333.04 | 267.13 |
Goodwill | 15.09 | 15.09 | 43.7 | 115.8 | 142.41 | 155.02 |
Other Intangible Assets | 28.42 | 30.36 | 33 | 34.3 | 29.82 | 31.32 |
Long-Term Accounts Receivable | - | - | - | 43.12 | 49.74 | 61.86 |
Long-Term Deferred Tax Assets | 125.88 | 115.12 | 152.62 | 197.21 | 126.13 | 82.49 |
Long-Term Deferred Charges | 14.57 | 19.93 | 30.22 | 24.94 | 31.46 | 34.02 |
Other Long-Term Assets | 5.36 | 2.46 | 39.06 | 50.03 | 61.71 | 142.27 |
Total Assets | 1,529 | 1,802 | 2,830 | 3,342 | 3,959 | 4,294 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 147.71 | 298.62 | 754.78 | 747.1 | 737.56 | 583.76 |
Accrued Expenses | 14.23 | 29 | 41.3 | 35.3 | 47.44 | 54.11 |
Short-Term Debt | 208.08 | 230.42 | 422.76 | 443.7 | 778.87 | 690.25 |
Current Portion of Long-Term Debt | 5.99 | 198.12 | 11.7 | 0.2 | 51.5 | 90 |
Current Portion of Leases | - | 6.7 | 12.71 | 9.2 | 15.63 | 20.21 |
Current Income Taxes Payable | 9.72 | 7.49 | 14.41 | 18.2 | 17.77 | 27.53 |
Current Unearned Revenue | 18.71 | 23.33 | 35.39 | 23.35 | 26.85 | 65.67 |
Other Current Liabilities | 84.43 | 79.09 | 78.4 | 118.42 | 160.81 | 204.99 |
Total Current Liabilities | 488.89 | 872.77 | 1,371 | 1,395 | 1,836 | 1,737 |
Long-Term Debt | 3.01 | 3.01 | 451.82 | 563.89 | 527.37 | 751.38 |
Long-Term Leases | 14.9 | 16.38 | 25.86 | 32.87 | 31.74 | 47.48 |
Long-Term Unearned Revenue | - | - | 0.05 | 0.07 | 0.14 | 0.15 |
Long-Term Deferred Tax Liabilities | 4.24 | 5.17 | 10.82 | 13.29 | 17.4 | 5.88 |
Other Long-Term Liabilities | 0.62 | 0.62 | 8.04 | 21.53 | 48.82 | 9.26 |
Total Liabilities | 511.67 | 897.96 | 1,868 | 2,027 | 2,462 | 2,551 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 225.79 | 210.19 | 190.99 | 202.1 | 203.52 | 205.02 |
Additional Paid-In Capital | 1,112 | 899.78 | 627.45 | 819.86 | 833.91 | 854.43 |
Retained Earnings | -172.87 | -116.86 | 90.43 | 299.67 | 456.65 | 611.46 |
Treasury Stock | -24.03 | -24.03 | -24.03 | -175.67 | -187.68 | -200.55 |
Comprehensive Income & Other | -57.3 | -24.39 | 49.46 | 64.95 | 96.18 | 91.72 |
Total Common Equity | 1,084 | 944.69 | 934.29 | 1,211 | 1,403 | 1,562 |
Minority Interest | -66.6 | -40.2 | 27.75 | 103.78 | 94.33 | 180.83 |
Shareholders' Equity | 1,017 | 904.49 | 962.04 | 1,315 | 1,497 | 1,743 |
Total Liabilities & Equity | 1,529 | 1,802 | 2,830 | 3,342 | 3,959 | 4,294 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 231.99 | 454.63 | 924.84 | 1,050 | 1,405 | 1,599 |
Net Cash (Debt) | -153.17 | -322.34 | -715.41 | -771.26 | -1,011 | -1,114 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.71 | -1.62 | -3.73 | -3.99 | -5.19 | -5.62 |
Filing Date Shares Outstanding | 237.3 | 206.21 | 187.01 | 191.73 | 193.12 | 198.02 |
Total Common Shares Outstanding | 237.3 | 206.21 | 187.01 | 191.73 | 193.12 | 198.02 |
Working Capital | 472.78 | 365.6 | 715.68 | 999.26 | 1,114 | 1,506 |
Book Value Per Share | 4.57 | 4.58 | 5.00 | 6.32 | 7.26 | 7.89 |
Tangible Book Value | 1,041 | 899.24 | 857.59 | 1,061 | 1,230 | 1,376 |
Tangible Book Value Per Share | 4.38 | 4.36 | 4.59 | 5.53 | 6.37 | 6.95 |
Buildings | - | 18.68 | 18.68 | 18.68 | 18.56 | 18.56 |
Machinery | - | 66.47 | 71.24 | 82.36 | 76.45 | 63.21 |
Construction In Progress | - | 1.97 | 2.25 | 8.59 | 3.43 | 12.09 |